TEJAL PATEL: Open Payments
NPI 1518621606 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 17 payments from 10 companies in 2025. Trend: 2023 $110 · 2024 $345 · 2025 $536
Food & beverage: $386Education: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $92 |
| Kite Pharma, Inc. | 3 | $89 |
| Incyte Corporation | 1 | $75 |
| SEAGEN INC. | 1 | $75 |
| Merz Pharmaceuticals, LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 1 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| PFIZER INC. | 1 | $23 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: Yescarta, IMBRUVICA, INBRIJA, HYQVIA, EPKINLY, TIVDAK, FOTIVDA, Padcev.
Industry payments across FL — which companies pay providers there.
